February 21st, 2012
For the seventh time since we became publicly traded in 1944, Johnson & Johnson has announced the appointment of a new CEO to lead our company and employees in our mission to serve the health care needs of patients and customers.
In a news release issued this evening, Johnson & Johnson announced that its Board of Directors has named Alex Gorsky Chief Executive Officer (CEO) of Johnson & Johnson, effective April 26, 2012, the date of the Company’s Annual Meeting of Shareholders. Alex was also nominated for election to the Board of Directors at the Annual Meeting. Our current Chairman and CEO Bill Weldon will remain Chairman of the Board of Directors and will work to transition leadership of the organization to Alex.
Alex offered this statement on today’s announcement: “I’m honored that the Board has placed such confidence in me, and I am also aware of the serious responsibilities that come with this office. Johnson & Johnson is a strong and extraordinary company with enormous opportunities to advance health and well being. I look forward to working with the best employees in the world to achieve future success the way we always have — through unwavering commitment to the principles of Our Credo.”